| __timestamp | Halozyme Therapeutics, Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 35942000 | 1860000 |
| Thursday, January 1, 2015 | 40028000 | 2963000 |
| Friday, January 1, 2016 | 45853000 | 6961000 |
| Sunday, January 1, 2017 | 53816000 | 11779000 |
| Monday, January 1, 2018 | 60804000 | 13697000 |
| Tuesday, January 1, 2019 | 77252000 | 15749000 |
| Wednesday, January 1, 2020 | 45736000 | 18638000 |
| Friday, January 1, 2021 | 50323000 | 27196000 |
| Saturday, January 1, 2022 | 143526000 | 31739000 |
| Sunday, January 1, 2023 | 149182000 | 33491000 |
| Monday, January 1, 2024 | 154335000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing expenses is crucial for sustaining growth and innovation. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Halozyme Therapeutics, Inc. and Protagonist Therapeutics, Inc. from 2014 to 2023.
Halozyme Therapeutics has seen a significant increase in SG&A expenses, growing by approximately 315% over the decade. This surge, peaking in 2023, reflects the company's strategic investments in expanding its market presence and operational capabilities.
Protagonist Therapeutics, while starting with lower expenses, has also experienced a notable rise, with a 1700% increase since 2014. This growth underscores its commitment to scaling operations and enhancing its competitive edge.
The contrasting trajectories of these companies highlight different strategic approaches in the biotech sector, offering valuable insights for investors and industry analysts.
Comparing SG&A Expenses: Eli Lilly and Company vs Halozyme Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: AbbVie Inc. vs Halozyme Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Halozyme Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Halozyme Therapeutics, Inc. or Taro Pharmaceutical Industries Ltd.
PTC Therapeutics, Inc. or Protagonist Therapeutics, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: MorphoSys AG vs Protagonist Therapeutics, Inc.
Comparing SG&A Expenses: Protagonist Therapeutics, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Wave Life Sciences Ltd.
Breaking Down SG&A Expenses: Protagonist Therapeutics, Inc. vs Dynavax Technologies Corporation
Protagonist Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Protagonist Therapeutics, Inc. vs Celldex Therapeutics, Inc.